DEBORAH CRISTINA LANDI MASQUIO

Prof. Dr. DEBORAH CRISTINA LANDI MASQUIO


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 July 2012 in Clinical Endocrinology
Verified
Journal Article
Closed access
PDF file
DMDEBORAH CRISTINA LANDI MASQUIO
DEBORAH CRISTINA LANDI MASQUIO
AGAline de Piano Ganen
Aline de Piano Ganen
PSPriscila L. Sanches
Priscila L. Sanches
FCFlávia C. Corgosinho
Flávia C. Corgosinho
RCRaquel Munhoz da Silveira Campos
Raquel Munhoz da Silveira Campos
ADANA RAIMUNDA DÂMASO
ANA RAIMUNDA DÂMASO

24 April 2015 in British Journal of Nutrition
Verified
Journal Article
Closed access
PDF file
DMDEBORAH CRISTINA LANDI MASQUIO
DEBORAH CRISTINA LANDI MASQUIO
AGAline de Piano Ganen
Aline de Piano Ganen
RCRaquel Munhoz da Silveira Campos
Raquel Munhoz da Silveira Campos
PSPriscila L. Sanches
Priscila L. Sanches
JCJune Carnier
June Carnier
ADANA RAIMUNDA DÂMASO
ANA RAIMUNDA DÂMASO
Obesity is characterised by low-grade inflammation, which increases the metabolic syndrome (MetS) and cardiovascular risks. The aim of the present study was to verify the role of multicomponent therapy in controlling the MetS, inflammation and carotid intima-media thickness (cIMT) in obese adolescents. The second aim was to investigate the relationships between adipokines, the MetS parameters and cIMT. A total of sixty-nine obese adolescents participated in the present study and completed 1 year of multicomponent therapy (a combination of strategies involving nutrition, psychology, physical exercise and clinical therapy), and were divided according to their MetS diagnosis as follows: MetS (n 19); non-MetS (n 50). Blood analyses of glucose, lipid and adipokine concentrations (adiponectin, leptin, plasminogen activator inhibitor 1 (PAI-1) and C-reactive protein) were collected. Insulin resistance was assessed using the homeostasis model assessment for insulin resistance, quantitative insulin sensitivity check index and homeostasis model assessment-adiponectin. cIMT and visceral and subcutaneous fat were estimated using ultrasonography. At baseline, the MetS group presented higher waist circumference, glucose and insulin levels, and systolic and median blood pressures compared with the non-MetS group. After therapy, both groups showed improvements in the anthropometric profile, body composition, insulin level, insulin resistance, insulin sensibility, TAG and VLDL-cholesterol, adiponectin, leptin and PAI-1 levels, blood pressure and cIMT. The prevalence of the MetS was reduced from 27·5 to 13·0 %. Metabolic syndrome patients showed resistance in the attenuation of total cholesterol and LDL-cholesterol (LDL-C) levels and leptin:adiponectin and adiponectin:leptin ratios. In the MetS group, the variation in the adiponectin:leptin ratio was correlated with variations in glucose, insulin sensibility, total cholesterol, LDL-c and systolic blood pressure. Additionally, the number of MetS parameters was correlated with the carotid measurement. Moreover, the variation in cIMT was correlated with the variations in insulin sensibility, total cholesterol and LDL-c. For the entire group, the number of MetS alterations was correlated with the leptin level and leptin:adiponectin ratio and adiponectin:leptin ratio after therapy. In conclusion, multicomponent therapy was effective in controlling the MetS, inflammation and cIMT in the obese adolescents. However, the MetS patients showed resistance in the attenuation of the atherogenic lipid profile and leptin:adiponectin ratio and adiponectin:leptin ratio. These results suggest that the MetS patients have increased cardiovascular risks, and that it is important to attempt to control the inflammatory process that occurs due to obesity in clinical practice in order to improve the health of adolescents.

1 July 2016 in The Journal of Nutritional Biochemistry
Verified
Journal Article
Closed access
DMDEBORAH CRISTINA LANDI MASQUIO
DEBORAH CRISTINA LANDI MASQUIO
AGAline de Piano Ganen
Aline de Piano Ganen
LOLila Missae Oyama
Lila Missae Oyama
RCRaquel Munhoz da Silveira Campos
Raquel Munhoz da Silveira Campos
ASAline Boveto Santamarina
Aline Boveto Santamarina
ADANA RAIMUNDA DÂMASO
ANA RAIMUNDA DÂMASO

9 August 2013 in Inflammation
Verified
Journal Article
Closed access
PDF file
PSPriscila L. Sanches
Priscila L. Sanches
Marco Tulio de MelloMarco Tulio de Mello
Marco Tulio de Mello
NENatália Elias
Natália Elias
FFFrancisco Antonio Antonio Helfenstein Helfenstein Fonseca
Francisco Antonio Antonio Helfenstein Helfenstein Fonseca
RCRaquel Munhoz da Silveira Campos
Raquel Munhoz da Silveira Campos
ADANA RAIMUNDA DÂMASO
ANA RAIMUNDA DÂMASO

9 October 2014 in International Journal Of Clinical Practice
Verified
Journal Article
Closed access
PDF file
DMDEBORAH CRISTINA LANDI MASQUIO
DEBORAH CRISTINA LANDI MASQUIO
AGAline de Piano Ganen
Aline de Piano Ganen
RCRaquel Munhoz da Silveira Campos
Raquel Munhoz da Silveira Campos
PSP. L. Sanches
P. L. Sanches
JCJ. Carnier
J. Carnier
ADANA RAIMUNDA DÂMASO
ANA RAIMUNDA DÂMASO
Background/Objectives Obesity is related to inflammation and cardiovascular disease. The increase in saturated fatty acid intake (SFA) can potentiate cardiovascular risks. The aim of this study was to assess the influence of change in SFA on carotid intima‐media thickness (cIMT), metabolic profile and anti/pro‐inflammatory adipokines in obese adolescents. Methods Sixty obese adolescents were subjected to 1 year of interdisciplinary intervention (nutrition, psychology, physical exercise and clinical therapy). Blood glucose, insulin, lipid profile, leptin and adiponectin were analysed. Insulin resistance was estimated by HOMA‐IR and HOMA‐AD. cIMT was measured by ultrasonography. Dietetic intake was calculated by 3‐day dietary record. Volunteers were analysed according to tertiles of change (Δ) in SFA intake: Low‐SFA reduction < 3.68 g; Moderate‐SFA reduction 3.68–13.67 g; and High‐SFA reduction > 13.67 g. Results Moderate and High‐SFA tertiles presented reduction in insulin, leptin/adiponectin ratio, cIMT and increase in adiponectin and adiponectin/leptin ratio. Adiponectin/leptin ratio was predictor of cIMT. HOMA‐IR, total cholesterol and LDL‐cholesterol reduced only in High‐SFA tertile, and was associated with SFA independent of visceral fat. Negative correlations between Δ of SFA and adiponectin and adiponectin/leptin ratio were observed. Conclusion Obese adolescents with moderate and high reduction in SFA presented improvements on pro/anti‐inflammatory biomarkers and cIMT, leading to reduction in cardiovascular risks.